Orange Book product · Brand (NDA)
QUTENZA
CAPSAICIN
Brand (NDA)NDA 022395RX AVERITAS
At a glance
Nov 16, 2009
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 16, 2009
16 yr 10 mo ago
Today
Patent 9226903 expires
Listed drug product patent expiration.
Dec 15, 2028
in 2 yr 6 mo
Patent 8821920 expires
Listed drug product patent expiration.
Mar 26, 2030
in 3 yr 10 mo
Pharmaceutical detail
Active ingredient
CAPSAICIN
Strength
8%
Dosage form
PATCH
Route
TOPICAL
TE code
Not listed
Application
NDA 022395
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9226903 | Dec 15, 2028 | in 2 yr 6 mo | Product |
| 8821920 | Mar 26, 2030 | in 3 yr 10 mo | Product |
